Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01421264 · ClinicalTrials.gov registry record · Phase 1
Gabapentin's Effects on Insomnia in Patients With Recent Concussion
A Phase 1 study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01421264 is a Phase 1 study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 21 participants.
The verdict
NCT01421264, a Phase 1 study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
In this open-label, pilot study the investigators will be assessing gabapentin's effects on insomnia and other concussion-related symptoms in patients with a recent concussion experiencing insomnia.
Interventions
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01421264
The ClinicalTrials.gov registry entry for NCT01421264 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gabapentin is the first listed.
NCT01421264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01421264 about?
NCT01421264 is a clinical study titled "Gabapentin's Effects on Insomnia in Patients With Recent Concussion". In this open-label, pilot study the investigators will be assessing gabapentin's effects on insomnia and other concussion-related symptoms in patients with a recent concussion experiencing insomnia.
What is the current status of trial NCT01421264?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2011-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01421264?
The interventions under investigation include: Gabapentin (DRUG).
Who is sponsoring clinical trial NCT01421264?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.